GlassScriptPhysician profile
Sabina Kumar
NPI 1194285676
$8,350.18
in general payments reported to CMS, 2019-2025
17 companies · $4,314 in 2025
The $4,314 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $112 · 2023: $3,221 · 2024: $703 · 2025: $4,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,965 · Travel and Lodging: $3,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,964.50 |
| Travel and Lodging | $3,273.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,012.46 | 2025 | Prostar, Aveir, Esprit |
| Inari Medical, INC. | $2,746.31 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $571.86 | 2023-2025 | Eluvia, Watchman Access System, Ranger |
| Abiomed | $515.88 | 2025 | |
| Shockwave Medical, INC | $326.32 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $226.41 | 2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $211.51 | 2022-2025 | Corevalve Evolut R, Micra, Linq II |
| Astrazeneca Pharmaceuticals LP | $188.86 | 2022-2024 | Farxiga, Wainua, Brilinta |
| Angiodynamics, INC. | $141.24 | 2023 | Alphavac |
| Philips North America LLC | $127.08 | 2025 | Azurion 7 M20 |
| Kestra Medical Technology Services, INC. | $114.53 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $48.73 | 2025 | Kengreal |
| Lexicon Pharmaceuticals, INC. | $35.92 | 2024 | |
| Alnylam Pharmaceuticals INC. | $26.99 | 2022 | |
| Amgen INC. | $25.95 | 2025 | Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.37 | 2024 | |
| Glaxosmithkline, LLC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabina Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.